Proline-Based Boronic Acid Receptors for Chiral Recognition of Glucose by Guo, Lin-E et al.
        
Citation for published version:
Guo, L-E, Hong, Y, Zhang, S-Y, Zhang, M, Yan, X-S, Cao, J-L, Li, Z, James, TD & Jiang, Y-B 2018, 'Proline-
Based Boronic Acid Receptors for Chiral Recognition of Glucose', Journal of Organic Chemistry, vol. 83, no. 24,
pp. 15128-15135. https://doi.org/10.1021/acs.joc.8b02425
DOI:
10.1021/acs.joc.8b02425
Publication date:
2018
Document Version
Peer reviewed version
Link to publication
This document is the Accepted Manuscript version of a Published Work that appeared in final form in The
Journal of Organic Chemistry, copyright © American Chemical Society after peer review and technical editing by
the publisher. To access the final edited and published work see
https://pubs.acs.org/doi/10.1021/acs.joc.8b02425
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 07. Dec. 2019
 Proline-Based Boronic Acid Receptors for Chiral Recognition of 
Glucose 
Lin-E Guo,a Yuan Hong,a Shu-Ying Zhang,a Miao Zhang,a Xiao-Sheng Yan,a Jin-Lian Cao,a Zhao Li,a 
Tony D. James, * b and Yun-Bao Jiang*a 
a Department of Chemistry, College of Chemistry and Chemical Engineering, The MOE Key Laboratory of Spectrochemical 
Analysis and Instrumentation, and iChEM, Xiamen University, Xiamen 361005, China.  
b Department of Chemistry, University of Bath, Bath BA2 7AY, UK. 
KEYWORDS: proline, chiral recognition, monosaccharide, 1H NMR, 19F NMR 
ABSTRACT: Chiral recognition remains a major challenge in the area of molecular receptor design. With this research we set out 
to explore the use of proline based receptors for chiral recognition. Importantly, the proline structure allows for the introduction of 
at least two different binding groups due to the availability of both an amine and carboxylic acid group.  Here we report a proof-of-
concept exploration into the chiral recognition of D-/L-glucose, as model chiral species which prefers to bind to at least two boronic 
acid groups. We evaluated several proline-based receptors incorporating two phenylboronic acid groups, respectively at the N- and 
C-termini of the amino acid residue, via amide bonds. We confirmed that the receptors exhibited chiral recognition using CD, 1H 
NMR and 19F NMR spectroscopy. Given the derivation diversity available, our strategy to use proline-based receptors for chiral 
recognition holds significant promise for extension to other chiral systems. 
INTRODUCTION 
While molecular recognition and chiral sensing have seen 
tremendous developments,1,2 chiral recognition remains a sig-
nificant challenge. In many of the reported examples, 1,1’-
binaphthol was the major structural framework that was de-
rived into receptors bearing two identical binding groups and 
in the majority of the cases macrocyclic receptors are pro-
duced.3-6 1,1’-Binaphthol and proline are two of the major 
frameworks used for constructing asymmetric organocata-
lysts,7-13 yet we noted that surprisingly much less attention has 
been paid to proline-based receptors for chiral recognition.2,14-
16 We therefore proposed that by using proline as a structural 
framework to construct receptors for chiral recognition could 
have several advantages, since it can contain at least two dif-
ferent binding groups at the N- and C-termini of the amino 
acid residue, the approach is simpler when compared to the 
1,1’-binaphthol framework since its two reactive sites at 2,2’-
positions, the -OHs, are the same in terms of reactivity and, 
subsequently, allows us to create receptors with larger struc-
tural diversity for a broader spectrum of chiral species. While 
the cis-/trans-conformation equilibrium of the proline resi-
due,17-19 in addition to its favorable cleft-shaped structure, can 
be employed to enhance chiral recognition. 
Here we report our proof-of-concept exploration into the 
development of proline-based receptors for chiral recognition, 
which in general requires multiple interactions of the receptor 
with the chiral species, so that the receptor contains at least 
two binding groups to allow the chiral center(s) of the chiral 
species to be included within the interaction network. Our first 
model system was aimed at developing receptors for the chiral 
recognition of L-/D-glucose, which has been shown to prefer 
binding with diboronic acid derivatives.20,21 Therefore, we 
designed diboronic acid derivatives of L-/D-proline, L-/D-1 to 4 
(Scheme 1a), which differ in the positions of the boronic acid 
groups on the phenyl rings at the N- and C-termini of proline 
residue. Their binding with L-/D-glucose was first investigated 
by circular dichroism (CD) spectroscopy, a powerful tool for 
chiral research.22-26 Next fluorine atoms were introduced into 
the phenyl rings to facilitate the use of spectrally simpler 19F 
NMR for receptor evaluation. Our results confirm that the 
proline-based receptors are indeed well suited towards chiral 
recognition. 
RESULTS AND DISCUSSION 
Absorption spectra of the four receptors of L-configuration, 
L-1 to L-4, were studied in optimized media consisting of 1:1 
(v/v) MeOH/0.05 M pH 10.0 NH4Cl-NH3·H2O buffer (Fig. 
S1). Despite the difference in the substitution positions of the 
two boronic acid groups, L-1 to L-4 all exhibit a major absorp-
tion around 245 nm with molar extinction coefficients of mag-
nitude 104 M-1 cm-1, indicative of the π-π* nature of the transi-
tion of the phenylboronic acid chromophores (Fig. S2). Simi-
lar observations were made with D-1 to D-4 (Fig. S3). Much to 
our delight, L-1 to L-4 all exhibited CD signals at the absorp-
tion wavelength (Fig. S2), suggesting that the chirality of  
 
 
 
  
Scheme1. (a) Chemical structures of stereoisomers of 1 to 10 and D-1Br investigated, and crystal structure of the intermedi-
ate D-1Br. L-5 and L-6, are monophenylboronic acid control compounds of L-1; L-/D-7 are alanine counterparts of L-/D-1. 
compounds L-8 to L-10 are fluorine-substituted L-1; The two boronic acid groups in 1-4 are substituted at the phenyl rings 
respectively at (L-/D-1) m,m’-, (L-/D-2) m,p’-, (L-/D-3) p,m’-, and (L-/D-4) p,p’-positions; fluorine atoms are introduced into 
the phenyl rings at different positions in L-8 to L-10 and are labelled as Fa and Fb, respectively; “*” on the structures high-
lights the chiral carbon. (b) Structures of the tested monosaccharide.
 
 
 
 
 
 
 
 
 the proline residue is transferred to the achiral phenylboronic 
acid chromophores. This was supported by the mirror-imaged 
CD spectra of the corresponding D-enantiomers D-1 to D-4 
(Fig. S4). Therefore, the structural advantage of the cleft-
shaped proline residue in rendering the binding sites chiral 
was fully demonstrated. 
We next evaluated the interactions of receptors L-/D-1 to 4 
with L-/D-glucose via absorption and CD titrations. Fig. 1a-d 
shows the absorption and CD spectral traces of L-1 upon 
addition of L- and D-glucose, respectively. Both the absorption 
and CD spectral responses of L-1 toward L-glucose are much 
more dramatic than those to D-glucose, in the latter cases the 
spectral variations are minor (Fig. 1b, d). Likewise, D-1 
exhibits chiral recognition toward D-glucose (Fig. 1e-h), while 
the CD spectral traces show mirror-image profiles for L-1/L-
glucose and D-1/D-glucose (Fig. S5). The chiral recognition is 
therefore driven by the intrinsic chirality of the proline 
residue. The observation of an isosbestic point at 258 nm in 
the absorption titration profiles of L-1 with L-glucose (Fig. 1a) 
suggests the  
 
Figure 1. Absorption (a, b, e, f) and CD (c, d, g, h) spectra of L-1 
(a-d) and D-1 (e-h) in the presence of L- or D-glucose in 1:1 (v/v) 
MeOH/0.05 M pH 10.0 NH4Cl-NH3·H2O buffer. [L-1] = [D-1] = 
30 μM, [glucose] = 0 - 6 mM. 
formation of a boronate of defined composition. This is 
significant since there are two boronic acid groups in L-1 and 
there are two cis-diol moieties in α-L-furanoglucose (Scheme 
1b) which can interact. Job plot experiments under total 
concentrations of o.5 mM and 1.0 mM both indicated a 1:1 
stoichiometry between L-1 and L-glucose (Fig. S6).27,28 Mass 
spectrometry provided direct evidence for the 1:1 interaction. 
A mixture of L-1 (3 mg) and 200 equivalents of L-glucose 
incubated in 1:1 (v/v) MeOH/0.05 M pH 10.0 NH3-NH4Cl 
buffer for 3 hr afforded a distinct peak at m/z 491.1795 (Fig. 
S7), which corresponds to the 1:1 cyclic diboronate of 
calculated m/z 491.1719 for C24H24B2N2O8 ([M+H]
+). Control 
compounds of L-1, L-5 and L-6 (Scheme 1a) that bear only one 
phenylboronic acid group were found to show very small 
spectral responses toward L-/D-glucose (Fig. S8 and S9). We 
therefore propose that a two-point interaction occurs between 
L-1 and L-glucose and that each phenylboronic acid group in 
L-1 interacts with a cis-diol moiety in L-glucose, leading to a 
cyclic boronate, likely in a cooperative manner. A substantial 
increase in the CD signal of L-1 upon interaction with L-
glucose supports this conclusion since it suggests a rigid 
conformation of the formed boronate. 
The elegant work of Drueckhammer et al.21 determined that 
in order to achieve strong binding with glucose the two 
boronic acid groups should be appropriately positioned. 
Therefore, we expected that the four receptors with different 
boronic acid positioning would display differential binding 
towards glucose. Comparative assays using CD signaling (Fig. 
S10) confirms that L-/D-1 exhibit the highest chiral recognition 
between the L-/D-enantiomers of glucose amongst receptors 1-
4. L-4, despite being less capable, showed chiral recognition 
towards L-glucose. Unlike the other receptors, L-2 exhibited a 
significant response in its CD at 244 nm toward L-glucose 
(Fig. S10c), while a distinct band at 255 nm was discovered in 
the presence of D-glucose (Fig. S10d). No significant  
Table 1. Binding constants of receptors 1-4 with L-/D-
glucose.a 
Receptor 
Ka ± sd, 103 M-1 
L-glucose D-glucose 
L-1 (m,m’-) 6.72 ± 0.66 0.85 ± 0.09 
D-1 (m,m’-) 0.62 ± 0.08 5.42 ± 0.55 
L-2 (m,p’-) 4.01 ± 0.23 3.36 ± 0.27 
D-2 (m,p’-) 3.56 ± 0.32 3.52 ± 0.93 
L-3 (p,m’-) ̶ [b] 0.48 ± 0.07 
D-3 (p,m’-) 0.68 ± 0.22 ̶ [b] 
L-4 (p,p’-) 0.51 ± 0.08 ̶ [b] 
D-4 (p,p’-) 0.64 ± 0.11 1.0 ± 0.11 
[a] Binding constants (Ka) were obtained by nonlinear fitting of the 
CD signal as a function of glucose concentration assuming a 1:1 
stoichiometry. [Receptor] = 30 μM, T = 298 K. [b] Due to minor 
changes in CD spectra accurate Ka values could not be fitted. 
change in the CD spectrum of L-3 was observed upon the 
addition of L-glucose (Fig. S10e), while a weak CD signal was 
observed in the presence of D-glucose (Fig. S10f). The binding 
constants (Ka) obtained using nonlinear fitting for a 1:1 
binding27 of the CD data are listed in Table 1, which indicates 
that the L-1/L-glucose and D-1/D-glucose binding of Ka (5 - 7) 
× 103 M-1 (Table 1) is stronger than that of the L-1/D-glucose 
and D-1/L-glucose of Ka (0.6 – 0.9) × 103 M-1 (For titration 
curves see Fig. S11 and S12), indicating the chiral recognition 
of L-1 towards L-glucose and D-1 towards D-glucose. 
Chiral recognition of receptor L-1 was also examined for 
other monosaccharides, such as D-/L-mannose, D-/L-xylose and 
 D-galactose that bear two sets of cis-diols yet of different 
distance or relative orientation, or D-fructose that bears only 
one set of cis-diol (Scheme 1b). No significant changes in the 
CD spectra were observed (Fig. S19 and S20), suggesting 
weak interaction occurred and the chiral recognition was not 
significant. This means that the ability of the proline-based 
receptor L-1 for chiral recognition of L- over D-glucose is 
highly selective. 
 
Figure 2. Chiral recognition for glucose by 1H NMR signalling. 
Partial 1H NMR spectra of L-1 upon addition of L-glucose (a), and 
L-1 (b) and D-1 (c) in the presence of 6 eq L-glucose and D-glucose, 
respectively, in pH 9 NH3-NH4Cl buffer in D2O. [1] = 5 mM; 
[NH4Cl] + [NH3] = 50 mM. 
For understanding the binding of 1 with glucose, we 
performed 1H NMR titrations. The resonances of protons on 
the aromatic ring (Fig. 2a) and the proline methylene region (δ 
2.0-2.5 ppm, Fig. S21) of L-1 in D2O buffer changed 
significantly upon addition of L-glucose. In particular, the 
resonances of the aromatic protons become well-resolved in 
the presence of 1 eq or more of L-glucose, indicating thatL-1 
binds tightly with L-glucose to generate a rigid structure,29 in 
agreement with the appearance of an isosbestic point in the 
absorption spectral evolution and adramatic change in CD 
signal (Fig. 1a, c). These observations support the two-point 
interaction mode for L-1 with L-glucose. Meanwhile, the 
signals of the methylene protons at 2.50 ppm disappear and 
new signals at 2.45 ppm appear (Fig. S21), indicating a shift of 
the conformation equilibrium of L-1 towards the cis-conformer 
upon the formation of the L-1/L-glucose boronates. A similar 
observation was made for the resonance around 2 ppm in that 
an enhancement of the resonances at around 2.10 ppm is 
accompanied by the disappearance of resonances at 1.95 ppm. 
Upon addition of D-glucose, however, resonances of the 
aromatic protons of L-1 became irregular and broad (Fig. 2b 
and S22). This is indicative of a weaker and loose interaction 
for L-1 with D-glucose. The 1H NMR titrations therefore 
confirmed that the chiral recognition of L-1 towards L-glucose 
results from the formation of the 1:1 cyclic diboronate 
complex via a two-point interaction (Fig. 3). This was further 
supported by the fact that the 1H NMR profiles remain 
unchanged when the titrations were performed at dilutting 
concentrations of L-1 of 4, 3, 2, 1, 0.5, 0.1 and 0.05 mM with 6 
eq of L-glucose (Fig. S23). Likewise the chiral recognition of 
D-1 for D-glucose over L-glucose was demonstrated in Fig. 2c, 
contrasting the well-resolved 1H NMR of D-1/D-glucose 
boronate complex with the irregular and blurred 1H NMR of 
D-1/L-glucose boronate complex. According to 1H NMR data, 
the trans- to cis-conformation ratio is ca. 1.3 in L-1, which 
dropped slightly to 1.0 in the L-1/L-glucose boronate (Fig. 
S24). 
DFT optimized structure of the trans-L-1 is slightly (3.61 kJ 
mol-1) more stable than the cis-conformer (Fig. S25a), which 
agrees with the observed trans-/cis-ratio of 1.3 in solution 
(Fig. 3). This was also supported by the crystal structure of the 
bromide precursor of D-1, D-1Br of the trans-conformation 
(Scheme 1a and Fig. S26) and the similar CD profiles of D-
1Br and D-1 (Fig. S27). Moreover, the optimized structures 
indicate that the boronates of both trans- and cis-forms of L-1 
are more stable than the corresponding L-1/D-glucose 
boronates, again showing the favored interactions of L-1 with 
L-glucose against D-glucose (Fig. S28 and S29). It should be 
pointed out that the two-point binding of L-1 with D-glucose 
was only assumed for the purpose of calculations, it actually 
did not exist as revealed by their huge energy difference and 
the irregular 1H NMR spectrum (Fig. 2b). Calculations showed 
that the optimized boronate of L-glucose of cis-form L-1 is 
more stable than that of the trans-form L-1 (Fig. S25b), which 
explained the lowered ratio of the L-glucose boronates of 
trans- to cis-L-1, being 1.0, compared to that (1.3) of the trans- 
to cis- L-1 (Fig. 2 and 3). 
 
  
Figure 3. DFT-optimized structures of trans- and cis-L-1 (a) and 
the corresponding boronates with L-glucose (b) in H2O at 
B3LYP/6-31G* level. The ratio of trans- to cis-conformation 
were calculated from 1H NMR data given in Figure S24. 
By using the more flexible alanine counterparts of L-/D-1, L-
/D-7 (Scheme 1a), we found that their absorption, CD, and 1H 
NMR did not change much in the presence of L- or D-glucose 
(Fig. S30-S32). These observations pointed to the important 
contribution of the rigidity of the proline residue in 1 for the 
chiral recognition of L-/D-glucose.17,19,30,31 
 
Figure 4. 19F NMR spectra of L-8 in the presence of given mono-
saccharide in pH 9.0 buffer in D2O. [L-8] = 5 mM, [saccharide] = 
30 mM. 
In order to establish the potential utility of the proline-based 
structural framework, we introduced fluorine atoms into the 
phenylboronic acid moieties so that the spectrally simpler 19F 
NMR32-36 might be employed to evaluate the chiral 
recognition. Fluorine-containing receptors L-8 to L-10 
(Scheme 1a) that correspond to L-1 were synthesized. Three 
sets of 19F NMR signals were observed for L-8 and were 
assigned to Fa and Fb on the two aromatic rings respectively 
(Scheme 1a), by referring to the 19F NMR spectra of L-9 and L-
10 (Fig. S33). Indeed, the 19F NMR spectra of L-8, L-9, and L-
10 are much simpler than the 1H NMR spectrum of L-1 (Fig. 
2a). 19F NMR spectra of L-8 and the complex formed on the 
addition of 6 equivalents of D-/L- monosaccharides are shown 
in Figure 4. Only with L-glucose, the 19F NMR of L-8 appeared 
as a well-resolved pattern, suggesting that L-8 and L-glucose 
forms a stable boronate of defined stoichiometry. This 
demonstrates the chiral recognition of L-8 for L-glucose, a 
conclusion that was also made for its analogue L-1 with L-
glucose shown by the 1H NMR and CD analyses. Again, the 
chiral recognition was observed for L-glucose, but not the 
other monosaccharides despite subtle differences in terms of 
the distance and relative orientation of the two sets of cis-diols 
(Fig. 1b). The ratios of the trans- to cis-conformation of free 
L-8 and L-8/L-glucose boronate are 1.3 and 1.0, respectively, 
calculated from the 19F NMR data (Fig. S34), close to those of 
L-1 and its L-glucose boronate obtained from 1H NMR data. 
Similar observations were found for L-9 and L-10 in their 19F 
NMR response toward L-glucose, producing well-resolved 
spectra (Fig. S35-S39). 19F NMR titrations also allowed the L-
/D-glucose binding constants of L-8 and L-10 to be evaluated 
as (2.5 ± 0.3) × 103 M-1/(0.4 ± 0.09) × 103 M-1 and (1.9 ± 0.4) 
× 103 M-1/(0.3 ± 0.04) × 103 M-1 (Table S2), respectively. 
Meanwhile, substantial changes in the absorption and CD 
spectra of L-8, L-9, and L-10 (Fig. S40-S42) allowed the 
binding constants with L-glucose to be evaluated as (3.62 ± 
0.17) × 103 M-1, (5.67 ± 0.28) × 103 M-1, and (3.48 ± 0.15) × 
103 M-1(see Fig. S43-S45, Table S3), respectively, comparable 
to those obtained from 19F NMR titrations. 
CONCLUSIONS 
In conclusion, we have successfully developed proline 
based receptors for chiral recognition. Highly efficient and 
selective chiral recognition was demonstrated for L-/D-glucose 
using the designed diboronic acid meta-substituted derivatives 
of rigid L-/D-proline constructed using amide bonds at both the 
N- and C-termini of the proline residue. The limited 
conformational flexibility of the receptor molecule, thanks to 
the conformational character of the proline residue, was shown 
to be locked within the formed of 1:1 cyclic diboronates with 
glucose using two-points of interaction. 1H NMR clearly 
displays the conformational change in the receptor molecule 
upon interaction with glucose since the formed boronate 
produces well-resolved NMR spectra. The strategy has been 
successfully extended by the introduction of fluorine atoms 
onto the phenyl rings of receptor L-1 thus enabling the use of 
spectrally simpler 19F NMR to determine the chiral recognition 
of L-8, L-9, or L-10 with L-glucose. The strategy of using the 
proline residue to build receptors for chiral recognition is 
expected to be of general utility, since suitable combinations 
of binding sites can be introduced stepwise to the N- and C-
termini of the proline residue. We are currently exploring the 
use of different receptors in order to develop a number of 
chiral receptors using this modular approach, preliminary 
work on chiral recognition of L-/D-Dopa appears to be 
promising. 
EXPERIMENTAL SECTION 
General Experimental Information. All reagents were 
purchased from commercial sources and were used without 
further purification. Solvents for spectral titrations were 
deionized water and redistilled MeOH. 
Details of the synthesis of 1 to 10 are given in the 
Supporting Information (SI) together with full characterization 
by 1H NMR, 13C NMR, and HRMS. Flash chromatography 
was carried out on silica gel (230−400 mesh). 1H NMR and 
13C NMR spectra (CDCl3 or CD3CN) were recorded on Bruker 
 AV500MHz, AV600MHz or AV850MHz spectrometer; 
highre solution mass spectra (HRMS) were acquired on 
Bruker En Apex ultra 7.0 TFT-MS spectrometer. The melting 
point range was recorded by Melting Point M-560. Circular 
dichroism (CD) spectra were obtained on Jasco J-810 or 
Biologic spectrometer. Absorption spectra were obtained on 
Thermo Evolution 300 spectrometer with a 1 cm standard 
quartz cell. Job plot was obtained from absorption 
measurements of 11 solutions with fixed total concentration of 
L-1 and L-glucose at 0.5 mM and 1 mM respectively.  
Absorption and CD spectral measurements were carried out 
using a stock solution of 1 of 2 mM in MeOH, which was di-
luted with 1:1 (v/v) MeOH/0.05 M pH 10.0 NH4Cl buffer to 
afford the desired concentration of 1 at 30 μM, to which 0 - 6 
mM of L-glucose and D-glucose or other guest species were 
added and recorded CD and UV spectra after 30 min.  
1H NMR and 19F NMR spectral measurements were record-
ed using a stock solution of 1 of 5 mM in D2O and adjusted 
the pH reach to 9 by NH4Cl and NaOD. L-/D-glucose and other 
monosaccharides were dissolved in D2O to obtained 0.1 M 
concentrated solutions. Then 0 - 30 mM (0 - 6 equivalent) of 
L- or D-glucose was added to solution 1 respectively, the 
mixture was incubated at 27 °C, after 30 min, the 1H NMR and 
19F NMR spectra were recorded using Bruker AV500MHz or 
AV600MHz spectrometer. 
General Procedure for Preparation of Proline based Re-
ceptors. 
General Procedure for the (a). Boc-L-proline (2.15 g, 10 
mmol) was dissolved in dichloromethane under stirring in ice 
bath, to which trimethylamine (2.5 mL) and isobutyl 
chloroformate (1.7 mL, 13 mmol) were added. The mixture 
was kept in ice-bath for 30 min. 3-Bromobenzenamine (1.09 
mL, 10 mmol) was next added dropwise and the solution was 
stirred at room temperature overnight. Solvent was removed in 
vacuo to lead to a crude mixture solid. This solid was washed 
with water, and the residue was washed with petroleum 
ether/EtOAc (8/1, v/v) (4 × 10 mL) to afford a white solid a 
(2.740 g, 74%), mp 211-212 °C. 1H NMR (850 MHz, CDCl3) 
δ (ppm) 9.65 (s, 1H), 7.82 (s, 1H), 7.34 (s, 1H), 7.14 (d, J = 
41.8 Hz, 2H), 4.47 (s, 1H), 3.39 (d, J = 74.6 Hz, 2H), 2.50 (s, 
1H), 2.06 - 1.84 (m, 3H), 1.51 (s, 9H). 13C{1H} NMR (214 
MHz, CDCl3) δ (ppm) 170.1, 156.7, 139.7, 130.1, 126.7, 122.5, 
118.0, 81.1, 60.5, 47.3, 28.4, 27.2, 24.6. HRMS (FTICR MS 
ESI+) [M+Na]+ calcd for C16H21NaBrN2O3: 391.0628, found 
391.0628. 
Boc Deprotection (b). a (2 g, 5.4 mmol) was dissolved in 
20 mL methylene dichloride. Then TFA (8 mL) was added to 
the mixed solution dropwise followed by stirring at room 
temperature for 2 h. Solvent was removed under reduced 
pressure to yield a white solid. 
General Procedure for the (c). m-Bromobenzoic acid 
(1.21 g, 6 mmol) in dichloromethane (10 mL) was stirred at 0 
oC, to which HOBt (1.05 g, 7.8 mmol), EDCI (1.72 g, 9 mmol), 
trimethylamine (5 mL, 36 mmol) were added and the resultant 
mixture was stirred at this temperature for 30 min. To this 
mixture was added dropwise the above white solid product 
dissolved in dichloromethane, which was allowed to react at 
room temperature overnight. The mixture was washed with 0.1 
M HCl (3 × 10 mL), saturated sodium bicarbonate solution (3 
× 10 mL), saturated sodium chloride solution (3 × 10 mL) 
respectively, and the organic layer was dried with anhydrous 
Na2SO4. The solution was evaporated to afford a crude oil. 
After washing with the mixed solvent of petroleum 
ether/EtOAc (5/1, v/v) (4 × 10 mL) to afforded a white solid c 
(1.970 g, 80.7 %), mp 220-221 °C. 1H NMR (500 MHz, 
CDCl3) δ (ppm) δ 9.61 (s, 1H), 7.82 (s, 1H), 7.71 (s, 1H), 7.61 
(d, J = 7.6 Hz, 1H), 7.49 (d, J = 7.0 Hz, 1H), 7.32 (dd, J = 16.2, 
7.8 Hz, 2H), 7.14 (d, J = 7.4 Hz, 1H), 7.06 (t, J = 7.6 Hz, 1H), 
4.93 (s, 1H), 3.58 (d, J = 42.9 Hz, 2H), 2.50 (s, 1H), 2.14 (s, 
2H), 1.91 (s, 1H). 13C{1H} NMR (125 MHz, CDCl3) δ (ppm) 
169.9, 169.1, 139.4, 137.7, 133.6, 130.2 130.16 , 130.0, 126.9, 
125.7, 122.6, 122.5, 122.5, 118.1, 61.1, 50.7, 27.5, 25.4. 
HRMS (FTICR MS ESI+) [M+Na]+ calcd for 
C18H16NaBr2N2O2: 472.9471, found 472.9475. 
General Procedure for L-1. c (1.97 g, 4.4 mmol), boric 
acid pinacol ester (3.35 g, 13.2 mmol) and KOAc (2.68 g, 26.4 
mmol) in DMF was stirred under nitrogen at room temperature 
for 30 min. Then Pd(dppf)Cl2 (0.2 g) was added. In nitrogen 
atmosphere, the mixture was stirred at 80 oC in oil bath for 24 
h. After which the mixture was allowed to cool down and 
filtered. The filtrate was evaporated in vacuo to obtain a crude 
mixture solid. The target compound L-1 was isolated by silica 
chromatography eluted by petroleum ether/ EtOAc (20/1 - 8/1, 
v/v) (0.800 g, 33 %), mp 210-221 °C. 1H NMR (500 MHz, 
CDCl3) δ (ppm) 9.48 (s, 1H), 7.94 (s, 1H), 7.87 (t, J = 6.9 Hz, 
2H), 7.82 (s, 1H), 7.60 (d, J = 7.7 Hz, 1H), 7.51 (d, J = 7.2 Hz, 
1H), 7.43 (t, J = 7.5 Hz, 1H), 7.32 (t, J = 7.7 Hz, 1H), 4.98 (dd, 
J = 7.8, 4.3 Hz, 1H), 3.53 (dtd, J = 17.4, 10.6, 7.0 Hz, 2H), 
2.69 (dt, J = 11.3, 5.9 Hz, 1H), 2.11 (tt, J = 13.6, 6.9 Hz, 1H), 
2.04 - 1.96 (m, 1H), 1.93 - 1.83 (m, 1H), 1.33 (d, J = 10.3 Hz, 
24H). 13C{1H} NMR (125 MHz, CDCl3) δ (ppm) 172.1, 168.6, 
137. 8, 136.6, 135.4, 133.2, 130.4, 129.8, 128.4, 127.9, 125.9, 
122.8, 84.1, 83.8, 60.7, 50.6, 26.3, 25.4, 24.9. HRMS (FTICR 
MS ESI+) [M+Na]+ calcd for C30H40NaB2N2O6: 569.2965, 
found 569.2976. 
Compounds 1-10 were synthesized by the same procedures. 
Compound D-1: White solid; 0.820 g, 34 % yield; mp 223-
224 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.50 (s, 1H), 
7.94 (s, 1H), 7.88 (d, J = 7.6 Hz, 2H), 7.82 (s, 1H), 7.60 (d, J = 
7.6 Hz, 1H), 7.51 (d, J = 7.2 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 
7.32 (t, J = 7.7 Hz, 1H), 4.99 (dd, J = 7.8, 4.3 Hz, 1H), 3.52 
(dtd, J = 17.4, 10.6, 6.9 Hz, 2H), 2.70 (td, J = 11.8, 6.3 Hz, 
1H), 2.17 - 2.06 (m, 1H), 2.04 - 1.96 (m, 1H), 1.93 - 1.82 (m, 
1H), 1.33 (d, J = 10.9 Hz, 24H). 13C{1H} NMR (125 MHz, 
CD3CN) δ (ppm) 171.3, 170.9, 139.3, 137.4, 136.7, 133.9, 
130.7, 129.4, 128.8, 126.4, 123.6, 85.1, 84.9, 62.3, 51.2, 29.9, 
26.1, 25.2. HRMS (FTICR MS ESI+) [M+H]+ calcd for 
C30H41B2N2O6: 547.3145, found 547.3155. 
Compound L-2: White solid; 0.780 g, 32 % yield; mp 147-
148 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.43 (s, 1H), 
7.97 - 7.72 (m, 4H), 7.51 (t, J = 7.5 Hz, 3H), 7.32 (t, J = 7.7 
Hz, 1H), 4.98 (d, J = 2.9 Hz, 1H), 3.49 (dtd, J = 17.2, 10.6, 6.8 
Hz, 2H), 2.68 (dd, J = 10.3, 5.0 Hz, 1H), 2.18 - 1.95 (m, 2H), 
1.94 - 1.81 (m, 1H), 1.33 (d, J = 17.0 Hz, 24H). 13C{1H} NMR 
(125 MHz, CDCl3) δ (ppm) 170.7, 167.7, 137.3, 136.7, 133.8, 
129.4, 127.4, 125.2, 124.8, 121.8, 83.1, 82.8, 59.7, 49.4, 25.5, 
24.4, 23.8. HRMS (FTICR MS ESI+) [M+Na]+ calcd for 
C30H40NaB2N2O6: 569.2965, found 569.2977. 
Compound D-2. White solid; 0.805 g, 33 % yield; mp 151-
152 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.42 (s, 1H), 
7.85 (dd, J = 13.5, 7.3 Hz, 4H), 7.51 (t, J = 7.2 Hz, 3H), 7.32 (t, 
J = 7.7 Hz, 1H), 4.97 (dd, J = 7.9, 4.3 Hz, 1H), 3.49 (ddt, J = 
 45.7, 10.6, 6.9 Hz, 2H), 2.67 (td, J = 11.8, 6.2 Hz, 1H), 2.16 - 
1.96 (m, 2H), 1.92 - 1.80 (m, 1H), 1.33 (d, J = 16.8 Hz, 24H). 
13C{1H} NMR (125 MHz, CDCl3) δ (ppm) 172.0, 168.7, 138.5, 
137.9, 134.9, 130.5, 128.5, 126.3, 126.0, 122.9, 84.3, 84.0, 
60.8, 50.6, 26.5, 25.5, 25.0. HRMS (FTICR MS ESI+) 
[M+Na]+ calcd for C30H40NaB2N2O6: 569.2965, found 
569.2974. 
Compound L-3. White solid; 0.793 g, 33 % yield; mp 232-
233 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.72 (s, 1H), 
7.93 (s, 1H), 7.88 (d, J = 7.4 Hz, 1H), 7.75 (d, J = 8.5 Hz, 2H), 
7.59 (t, J = 7.0 Hz, 3H), 7.43 (t, J = 7.6 Hz, 1H), 4.99 (dd, J = 
7.8, 4.1 Hz, 1H), 3.62 - 3.43 (m, 2H), 2.70 (dt, J = 11.6, 6.1 Hz, 
1H), 2.15 - 1.95 (m, 2H), 1.87 (tt, J = 13.1, 6.7 Hz, 1H), 1.33 
(d, J = 2.2 Hz, 24H). 13C{1H} NMR (125 MHz, CDCl3) δ 
(ppm) 172.2, 168.9, 141.0, 136.8, 135.8, 135.4, 133.2, 129.9, 
128.0, 118.9, 84.2, 83.8, 60.9, 50.8, 26.5, 25.5, 25.0. HRMS 
(FTICR MS ESI+) [M+H]+ calcd for C30H41B2N2O6: 547.3145, 
found 547.3158. 
Compound D-3. White solid; 0.840 g, 35 % yield; mp 233-
234 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.73 (s, 1H), 
7.93 (s, 1H), 7.88 (d, J = 7.4 Hz, 1H), 7.75 (d, J = 8.4 Hz, 2H), 
7.59 (t, J = 6.9 Hz, 3H), 7.43 (t, J = 7.5 Hz, 1H), 4.99 (dd, J = 
7.9, 4.3 Hz, 1H), 3.53 (ddt, J = 49.9, 10.5, 6.8 Hz, 2H), 2.70 
(dt, J = 11.6, 6.1 Hz, 1H), 2.05 (ddt, J = 47.4, 20.3, 7.3 Hz, 
2H), 1.87 (tt, J = 12.7, 6.4 Hz, 1H), 1.33 (d, J = 2.1 Hz, 24H). 
13C{1H} NMR (125 MHz, CDCl3) δ (ppm) 172.3, 168.9, 141.0, 
136.8, 135.8, 135.4, 133.2, 129.9, 128.0, 118.9, 84.3, 83.8, 
60.9, 50.8, 26.5, 25.5, 25.0. HRMS (FTICR MS ESI+) [M+H]+ 
calcd for C30H41B2N2O6: 547.3145, found 547.3158. 
Compound L-4. White solid; 0.823 g, 34 % yield; mp 296-
297 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.65 (s, 1H), 
7.86 (d, J = 8.0 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.58 (d, J = 
8.4 Hz, 2H), 7.49 (d, J = 8.0 Hz, 2H), 4.98 (dd, J = 8.0, 4.3 Hz, 
1H), 3.49 (ddt, J = 39.4, 10.7, 6.8 Hz, 2H), 2.69 (dt, J = 17.2, 
6.1 Hz, 1H), 2.16 - 1.95 (m, 2H), 1.87 (tt, J = 12.5, 6.3 Hz, 
1H), 1.34 (d, J = 10.1 Hz, 24H). 13C{1H} NMR (125 MHz, 
CDCl3) δ (ppm) 172.0, 168.9, 141.0, 138.3, 135.8, 134.9, 
131.7, 126.3, 121.3, 118.8, 84.2, 83.8, 60.9, 50.6, 26.6, 25.5, 
25.0. HRMS (FTICR MS ESI+) [M+H]+ calcd for 
C30H41B2N2O6: 547.3145, found 547.3159. 
Compound D-4. White solid; 0.770 g, 32 % yield; mp 300-
301 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.67 (s, 1H), 
7.86 (d, J = 7.3 Hz, 2H), 7.75 (d, J = 7.8 Hz, 2H), 7.58 (d, J = 
7.8 Hz, 2H), 7.49 (d, J = 7.4 Hz, 2H), 4.99 (dd, J = 5.4, 2.5 Hz, 
1H), 3.49 (dq, J = 23.1, 8.4 Hz, 2H), 2.69 (dd, J = 10.0, 5.1 Hz, 
1H), 2.17 - 1.94 (m, 2H), 1.93 - 1.80 (m, 1H), 1.34 (d, J = 10.0 
Hz, 24H). 13C{1H} NMR (125 MHz, CDCl3) δ (ppm) 172.2, 
168.7, 141.1, 138.4, 135.9, 135.0, 131.9, 126.3, 121.5, 118.9, 
84.3, 83.8, 60.9, 50.6, 26.3, 25.5, 25.0. HRMS (FTICR MS 
ESI+) [M+Na]+ calcd for C30H40NaB2N2O6: 569.2965, found 
569.2982. 
Compound L-5. White solid; 0.910 g, 43 % yield; mp 214-
215 °C. 1H NMR (850 MHz, CDCl3) δ (ppm) 9.62 (s, 1H), 
7.96 (s, 1H), 7.91 (d, J = 7.3 Hz, 1H), 7.62 (d, J = 7.6 Hz, 1H), 
7.59 (d, J = 7.9 Hz, 2H), 7.46 (t, J = 7.5 Hz, 1H), 7.32 (t, J = 
7.8 Hz, 2H), 7.10 (t, J = 7.2 Hz, 1H), 5.01 (dd, J = 7.8, 4.4 Hz, 
1H), 3.56 (ddt, J = 84.3, 10.6, 6.9 Hz, 2H), 2.71 (td, J = 11.9, 
6.3 Hz, 1H), 2.19 - 1.86 (m, 3H), 1.36 (s, 12H). 13C{1H} NMR 
(214 MHz, CDCl3) δ (ppm) 171.9, 168.9, 138.3, 136.7, 135.4, 
133.1, 129.8, 128.8, 127.9, 123.9, 119.8, 84.1, 60.8, 50.6, 26.8, 
25.4, 24.6. HRMS (FTICR MS ESI+) [M+Na]+ calcd for 
C24H29NaBN2O4: 443.2113, found 443.2114. 
Compound L-6. White solid; 0.830 g, 39 % yield; mp 212-
213 °C. 1H NMR (850 MHz, CDCl3) δ (ppm) 9.44 (s, 1H), 
7.89 (d, J = 6.9 Hz, 1H), 7.85 (s, 1H), 7.55 (t, J = 7.4 Hz, 3H), 
7.51 - 7.47 (m, 1H), 7.46 (t, J = 6.7 Hz, 2H), 7.35 (t, J = 7.4 
Hz, 1H), 5.02 (s, 1H), 3.57 (d, J = 54.8 Hz, 2H), 2.72 (s, 1H), 
2.22 - 2.01 (m, 2H), 1.91 (s, 1H), 1.34 (s, 12H). 13C{1H} NMR 
(214 MHz, CDCl3) δ (ppm) 171.9, 168.8, 137.8, 135.9, 130.5, 
130.4, 128.5, 128.4, 127.2, 125.9, 122.8, 83.9, 60.7, 50.6, 26.5, 
25.5, 24.9, 24.9. HRMS (FTICR MS ESI+) [M+Na]+ calcd for 
C24H29NaBN2O4: 443.2113, found 443.2115. 
Compound L-7: White solid; 0.520 g, 53 % yield; mp 134-
135 °C. 1H NMR (600 MHz, CDCl3) δ (ppm) 9.12 (s, 1H), 
8.21 (s, 1H), 8.03 (d, J = 7.7 Hz, 1H), 7.98 (d, J = 7.3 Hz, 1H), 
7.95 (s, 1H), 7.80 (d, J = 7.7 Hz, 1H), 7.56 (d, J = 7.2 Hz, 1H), 
7.49 (t, J = 7.6 Hz, 1H), 7.34 (t, J = 7.7 Hz, 1H), 7.18 (d, J = 
7.1 Hz, 1H), 5.10 (dd, J = 13.9, 6.8 Hz, 1H), 1.66 (d, J = 6.9 
Hz, 3H), 1.36 (d, J = 22.5 Hz, 24H). 13C{1H} NMR (151 MHz, 
CDCl3) δ (ppm) 170.7, 167.8, 138.4, 137.5, 133.0, 132.8, 
130.84, 130.7, 128.5, 128.4, 126.2, 123.3, 84.3, 84.0, 50.3, 
25.0, 24.99, 24.98, 24.96, 18.7. HRMS (FTICR MS ESI+) 
[M+Na]+ calcd for C28H38NaB2N2O6: 543.2808, found 
543.2803. 
Compound D-7. White solid; 0.600 g, 56 % yield; mp 132-
133 °C. 1H NMR (600 MHz, CDCl3) δ (ppm) 9.10 (s, 1H), 
8.21 (s, 1H), 8.03 (d, J = 7.8 Hz, 1H), 7.98 (d, J = 7.3 Hz, 1H), 
7.94 (s, 1H), 7.81 (d, J = 7.9 Hz, 1H), 7.56 (d, J = 7.3 Hz, 1H), 
7.53 - 7.44 (m, 1H), 7.34 (t, J = 7.7 Hz, 1H), 7.15 (dd, J = 22.6, 
7.4 Hz, 1H), 5.43 - 4.84 (m, 1H), 1.66 (d, J = 6.9 Hz, 3H), 1.36 
(d, J = 22.5 Hz, 24H). 13C{1H} NMR (151 MHz, CDCl3) δ 
(ppm) 170.7, 167.8, 138.4, 137.5, 133.0, 132.7, 130.8, 130.7, 
128.6, 128.4, 126.2, 123.3, 84.3, 84.0, 50.3, 25.0, 24.99, 24.98, 
24.96, 18.7. HRMS (FTICR MS ESI+) [M+Na]+ calcd for 
C28H38NaB2N2O6: 543.2808, found 543.2816. 
Compound L-8. White solid; 0.430 g, 49 % yield; mp 182-
183 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.55 (s, 1H), 
7.84 (d, J = 11.0 Hz, 1H), 7.70 (s, 1H), 7.56 (dd, J = 8.6, 2.3 
Hz, 1H), 7.43 (s, 1H), 7.31 (d, J = 8.7 Hz, 1H), 7.19 (dd, J = 
8.4, 2.2 Hz, 1H), 4.94 (dd, J = 7.9, 4.4 Hz, 1H), 3.59 (dt, J = 
10.6, 6.8 Hz, 1H), 3.47 (dt, J = 10.7, 7.0 Hz, 1H), 2.68 (td, J = 
12.0, 6.3 Hz, 1H), 2.12 (dq, J = 14.1, 7.1 Hz, 1H), 2.01 (dt, J = 
15.1, 7.5 Hz, 1H), 1.95 - 1.85 (m, 1H), 1.32 (d, J = 11.6 Hz, 
24H). 13C{1H} NMR (125 MHz, CDCl3) δ (ppm) 170.7, 168.5, 
163.5, 163.0, 161.8, 161.4, 139.3, 139.2, 137.31, 137.27, 
128.8, 123.2, 123.1, 121.2, 117.1, 117.0, 116.4, 116.2, 110.2, 
110.0, 84.5, 84.2, 60.9, 50.6, 26.3, 25.4, 24.9, 24.8. HRMS 
(FTICR MS ESI+) [M+Na]+ calcd for C30H38NaB2F2N2O6: 
605.2776, found 605.2787. 
Compound L-9. White solid; 0.420 g, 52 % yield; mp 216-
217 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.72 (s, 1H), 
7.94 (s, 1H), 7.88 (d, J = 7.3 Hz, 1H), 7.84 (d, J = 11.0 Hz, 
1H), 7.60 (d, J = 7.6 Hz, 1H), 7.44 (t, J = 7.5 Hz, 2H), 7.21 - 
7.15 (m, 1H), 4.97 (dd, J = 7.9, 4.4 Hz, 1H), 3.65 - 3.53 (m, 
1H), 3.52 - 3.41 (m, 1H), 2.68 (td, J = 11.5, 6.0 Hz, 1H), 2.10 
(dq, J = 20.1, 6.7 Hz, 1H), 2.00 (dt, J = 20.4, 7.5 Hz, 1H), 1.95 
- 1.82 (m, 1H), 1.32 (d, J = 15.3 Hz, 24H). 13C{1H} NMR (125 
MHz, CDCl3) δ (ppm) 172.3, 168.7, 163.5, 161.8, 139.4, 139.3, 
 136.7, 135.2, 133.1, 129.8, 127.9, 121.2, 116.3, 116.1, 110.2, 
110.0 (d, J = 20.5 Hz), 84.2, 84.1, 60.7, 50.7, 26.1, 25.4, 25.0, 
24.9, 24.8. HRMS (FTICR MS ESI+) [M+Na]+ calcd for 
C30H39NaB2FN2O6: 587.2870, found 587.2876. 
Compound L-10. White solid; 0.500 g, 44 % yield; mp 181-
182 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.33 (s, 1H), 
7.86 (d, J = 8.1 Hz, 1H), 7.81 (s, 1H), 7.71 (s, 1H), 7.55 (d, J = 
7.2 Hz, 1H), 7.52 (d, J = 7.2 Hz, 1H), 7.32 (dd, J = 13.3, 6.2 
Hz, 2H), 4.95 (s, 1H), 3.58 (dd, J = 11.8, 5.2 Hz, 1H), 3.52 - 
3.42 (m, 1H), 2.68 (d, J = 5.5 Hz, 1H), 2.18 - 2.08 (m, 1H), 
2.02 (dd, J = 12.8, 7.1 Hz, 1H), 1.90 (dd, J = 12.4, 6.3 Hz, 1H), 
1.33 (d, J = 7.5 Hz, 24H). 13C{1H} NMR (125 MHz, CDCl3) δ 
(ppm) 170.6, 168.4, 163.0, 161.4, 137.7, 137.5, 137.4, 130.5, 
128.8, 128.4, 125.9, 123.1, 123.0, 122.8, 84.5, 83.9, 60.8, 50.6, 
26.4, 25.5, 24.88, 24.85. HRMS (FTICR MS ESI+) [M+Na]+ 
calcd for C30H39NaB2FN2O6: 587.2870, found 587.2876. 
Compound D-1Br. White solid; 1.988 g, 81.5 %, mp 223-
224 °C. 1H NMR (500 MHz, CDCl3) δ (ppm) 9.63 (s, 1H), 
7.82 (s, 1H), 7.70 (s, 1H), 7.62 (t, J = 13.4 Hz, 1H), 7.47 (t, J = 
10.3 Hz, 1H), 7.31 (dd, J = 16.4, 8.2 Hz, 2H), 7.14 (d, J = 7.9 
Hz, 1H), 7.06 (t, J = 8.0 Hz, 1H), 5.00-4.87 (m, 1H), 3.62 (dd, 
J = 11.4, 5.7 Hz, 1H), 3.57-3.47 (m, 1H), 2.57-2.42 (m, 1H), 
2.26-2.07 (m, 2H), 1.93 (ddd, J = 18.3, 14.6, 5.9 Hz, 1H). 13C 
NMR (125 MHz, CDCl3) δ (ppm) 169.8, 169.0, 139.4, 137.7, 
133.6, 130.2, 130.2, 130.0, 126.9, 125.7, 122.7, 122.5, 122.5, 
118.0, 61.1, 50.7, 27.4, 25.4. HRMS (FTICR MS ESI+) 
[M+Na]+ calcd for C18H16NaBr2N2O2: 472.9471, found 
472.9477. 
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